Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St.

• If you are trying to figure out whether Recursion Pharmaceuticals is attractively priced or a high risk speculation, a useful starting point is understanding what the current market price might be implying about its future.

• The stock last closed at US$3.58, with returns of 0.6% over 7 days, a 23.7% decline over 30 days, a 14.8% decline year to date, and a 57.9% decline over 1 year. This naturally raises questions about how sentiment and risk are being reflected in the valuation.

• Recent news coverage has focused on Recursion Pharmaceuticals as a high profile name in the biotech and drug discovery space, which…